Skip to content

Study · Non-randomized trial · 2006

3 results

[Pilot clinical trial of ladasten].

Siuniakov SA, Grishin SA, Teleshova ES, Neznamov GG, Seredenin SB

Eksperimental'naia i klinicheskaia farmakologiia1 Jul 2006

PMID16995430 (opens in a new tab)PepBankPUB-16995430
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with psychogenic asthenic disorder, ladasten showed therapeutically significant stimulant effects.

    In plain wordsIn patients with psychogenic asthenic disorder, ladasten showed stimulant effects.

    Peptide
    Bromantane
    Outcome
    IncreaseStimulant effects
    Study

    n: not reported in source

    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Ladasten exhibits a unique combination of therapeutically significant stimulant and anxiolytic effects, which is unusual of psychostimulants.
    1 context sentence
    Summary · context
    The psychotropic actibn and efficacy of ladasten, a new psychostimulant with anxiolitic activity, was studied in a standard clinical trial involving therapy of patients with psychogenic asthenic disorder.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with psychogenic asthenic disorder, ladasten showed therapeutically significant anxiolytic effects.

    In plain wordsIn patients with psychogenic asthenic disorder, ladasten showed anxiety-reducing effects.

    Peptide
    Bromantane
    Outcome
    DecreaseAnxiolytic effects
    Study

    n: not reported in source

    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Ladasten exhibits a unique combination of therapeutically significant stimulant and anxiolytic effects, which is unusual of psychostimulants.
    1 context sentence
    Summary · context
    The psychotropic actibn and efficacy of ladasten, a new psychostimulant with anxiolitic activity, was studied in a standard clinical trial involving therapy of patients with psychogenic asthenic disorder.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with psychogenic asthenic disorder, single-dose psychopathology and self-test results showed predominantly psychostimulant action of ladasten.

    In plain wordsIn patients with psychogenic asthenic disorder, single-dose assessments showed predominantly stimulant effects of ladasten.

    Peptide
    Bromantane
    Outcome
    IncreasePredominant single-dose psychostimulant action
    Study

    n: not reported in source

    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · single administrationAs given in this study (human).

    Source sentences

    Summary
    At the same time, the results of ladasten action upon single administration on the dynamics of psychopatological disorders and psychological self-test indexes show that the psychostimulant action is predominating.
    1 context sentence
    Summary · context
    The psychotropic actibn and efficacy of ladasten, a new psychostimulant with anxiolitic activity, was studied in a standard clinical trial involving therapy of patients with psychogenic asthenic disorder.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.